Advertisement
Organisation › Details
OrthoSera GmbH
Founded in 2012 and located in Krems an der Donau/Austria Lacerta Technologies GmbH is a clinicalstage regenerative medicine company aiming to translate research results into products for routin clinical use. We put special emphasis on designing simple and affordable protocols allowing a wider patient population to benefit from cell therapy. Our current development projects include an innovative albumin-coated bone allograft and a point-ofcare device for the personalised production of autologous serum products. *
Start | 2015-11-26 renamed | |
Group | OrthoSera (Group) | |
Predecessor | Lacerta Technologies GmbH | |
Industry | medical device | |
Industry 2 | tissue engineering / regenerative medicine | |
Person | Lacza, Zsombor (Lacerta Technologies GmbH 201404 CEO + Founder) | |
Person 2 | Ehring, Björn (Lacerta Technologies GmbH 201404 CFO + Business Angel Investor) | |
Region | Krems a. d. Donau | |
Country | Austria | |
City | n. a. | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: | ||
Record changed: 2023-06-26 |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top